Full Ingredients: Water, Glycerin, Stearic Acid, Centella Asiatica Extract (8.4%), Lauric Acid, Potassium Hydroxide, Myristic Acid, 1,2-Hexanediol, Glycol Distearate, Coco-glucoside, Potassium Cocoyl Glycinate, Sorbitan Olivate, Glutathione (1,000ppm), Beeswax, Niacinamide (1,000ppm), Glyceryl Stearate, PEG-100 Stearate, Polysorbate 60, Nelumbo Nucifera Extract, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Saccharomyces Ferment, Butylene Glycol, Solanum Melongena (Eggplant) Fruit Extract, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Hydrolyzed Collagen, Beta-Glucan, Hippophae Rhamnoides Fruit Extract, Dipropylene Glycol, Hydroxypropyl Methylcellulose, Madecassic Acid, Asiaticoside, Asiatic Acid, Squalane, Sodium Hyaluronate, Disodium EDTA, Caprylic/Capric Triglyceride, Hydrogenated Lecithin, Cholesterol, Xanthan Gum.
Lilly's TRIUMPH clinical program includes multiple Phase III trials evaluating retatrutide across different patient populations and endpoints: Seven additional Phase III readouts are expected throughout 2026, covering populations with type 2 diabetes, cardiovascular disease, obstructive sleep apnea, and other obesity-related comorbidities Cardiovascular outcomes data the gold standard for demonstrating that weight loss translates into reduced heart attacks, strokes, and cardiovascular death will be critical for retatrutide's regulatory and commercial positioning Head-to-head trials comparing retatrutide directly to existing therapies may provide definitive comparative efficacy data The Drug vs
En este momento no aceptamos reclamaciones de seguros
Results Sixty-nine VPA-poisoned patients (40F/29 M
